A First Insight into the Biological Activity Profile of Individual Compounds of Valeriana officinalis L.

Valeriana officinalis L. is a widely spread representative of the Eurasian flora. Preparations based on valerian extracts are recognized as sedatives, antidepressants, and anxiolytics by both traditional and modern medicine. Despite the extremely high interest in the biological and pharmacological properties of valerian extracts, the composition of biologically active substances and specific activities of their components are still not completely studied. Therefore, here we address the metabolic profiles of the valerian plants with a special emphasis on their major root constituents with pronounced neuroprotective activity. The following phytochemical analysis of the V. officinalis roots led to isolation of nine compounds, including two previously undescribed iridoids—isovaltrate isovaleroyloxyisohydrin (1) and isovaltrate α-(isovaleroxy)isovaleroxyhydrin (2)—together with one previously undescribed valerenic acid derivative—2-oxovalerenic acid (3). Three previously described iridoids—iridoidvol A (4), isovaltrate isovaleroyloxyhydrin (5), and valtrate hydrine B1 (6)—along with valerenic acid (7) and its metabolites—hydroxyvalerenic (8) and acetoxyvalerenic acids (9)—were isolated. Functional assays accomplished with the isolated compounds revealed moderate antioxidant activity characteristic for all of them. Moreover, a distinct neuroprotective potential was observed for the compound 3 (and, to a lesser extent, compound 8). This potential was manifested by a preliminary antineurodegenerative effect in the model of Aβ25–35 induced cytotoxicity. In respect of thrombin-induced platelet aggregation, compounds 1, 4, and 7 demonstrated pronounced inhibitory activity, whereas compounds 2, 5, and 6 showed distinct potentiating activity. Valerenic acid showed activity on TRPV1 ion channels, manifested by both channel activation and potentiation of the capsaicin response in CHO cells expressing TRPV1. Moderate antioxidant activity was characteristic of all compounds.

Authors

Institutions

Publication Details

Journal
International Journal of Molecular Sciences
Published
2026-09-30
DOI
https://doi.org/10.3390/ijms27198756
Primary Topic
Medicinal Plant Extracts Effects
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

A First Insight into the Biological Activity Profile of Individual Compounds of Valeriana officinalis L.

Toni Ditfe, Yuliya V. Korolkova, Margarita Shamatova, С. Н. Смирнов et al.
International Journal of Molecular Sciences
Medicinal Plant Extracts Effects
article

A First Insight into the Biological Activity Profile of Individual Compounds of Valeriana officinalis L.

Toni Ditfe, Yuliya V. Korolkova, Margarita Shamatova, С. Н. Смирнов, Sergey A. Kozlov, Eugene A. Rogozhin, Alena Soboleva, Stepan P. Gambaryan, Andrei Kenneth Whaley, Anastasiia O. Whaley, Andrej Frolov, Anastasia Orlova, Stanislav Sukhikh, Darya Meshalkina
article en

Abstract

Valeriana officinalis L. is a widely spread representative of the Eurasian flora. Preparations based on valerian extracts are recognized as sedatives, antidepressants, and anxiolytics by both traditional and modern medicine. Despite the extremely high interest in the biological and pharmacological properties of valerian extracts, the composition of biologically active substances and specific activities of their components are still not completely studied. Therefore, here we address the metabolic profiles of the valerian plants with a special emphasis on their major root constituents with pronounced neuroprotective activity. The following phytochemical analysis of the V. officinalis roots led to isolation of nine compounds, including two previously undescribed iridoids—isovaltrate isovaleroyloxyisohydrin (1) and isovaltrate α-(isovaleroxy)isovaleroxyhydrin (2)—together with one previously undescribed valerenic acid derivative—2-oxovalerenic acid (3). Three previously described iridoids—iridoidvol A (4), isovaltrate isovaleroyloxyhydrin (5), and valtrate hydrine B1 (6)—along with valerenic acid (7) and its metabolites—hydroxyvalerenic (8) and acetoxyvalerenic acids (9)—were isolated. Functional assays accomplished with the isolated compounds revealed moderate antioxidant activity characteristic for all of them. Moreover, a distinct neuroprotective potential was observed for the compound 3 (and, to a lesser extent, compound 8). This potential was manifested by a preliminary antineurodegenerative effect in the model of Aβ25–35 induced cytotoxicity. In respect of thrombin-induced platelet aggregation, compounds 1, 4, and 7 demonstrated pronounced inhibitory activity, whereas compounds 2, 5, and 6 showed distinct potentiating activity. Valerenic acid showed activity on TRPV1 ion channels, manifested by both channel activation and potentiation of the capsaicin response in CHO cells expressing TRPV1. Moderate antioxidant activity was characteristic of all compounds.

International Journal of Molecular SciencesVol. 27(19)
Russian Academy of Sciences (RU), Immanuel Kant Baltic Federal University (RU), Institute of Evolutionary Physiology and Biochemistry (RU), St Petersburg University (RU), Saint - Petersburg State Chemical Pharmaceutical Academy (RU), Institute of Bioorganic Chemistry (RU), Leibniz Institute of Plant Biochemistry (DE), Pharmaceutical Formulations (United States) (US), Timiryazev Institute of Plant Physiology (RU)
Openalex Percentile: Top 6%
Medicinal Plant Extracts Effects
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.